![]() |
Market Research Report
Global Biosimilars and Follow-On Biologics Market 2020-2030: Monoclonal Antibodies, Fusion Proteins, Insulin, Erythropoietin's, Granulocyte Colony-Stimulating Factor, Interferons, Growth/Fertility Hormones, Blood Disorders, Others |
||||||
Published by | Visiongain Ltd | Product code | 940964 | ||||
Published | Content info | 420 Pages Delivery time: 1-2 business days |
|||||
Price |
|
Global Biosimilars and Follow-On Biologics Market 2020-2030: Monoclonal Antibodies, Fusion Proteins, Insulin, Erythropoietin's, Granulocyte Colony-Stimulating Factor, Interferons, Growth/Fertility Hormones, Blood Disorders, Others | ||
Published: April 30, 2020 | Content info: 420 Pages |
|
The global biosimilars and follow-on biologics market is estimated to have reached $19.87bn in 2019 and expected to grow at a CAGR of 7.1% in the first half of the forecast period. The market is dominated by Biosimilar Monoclonal Antibodies, this submarket is estimated to hold 36.5% share of this market in 2020.
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 420-page report you will receive 131 tables and 90 figures- all unavailable elsewhere.
The 420-page report provides clear detailed insight into the global biosimilars and follow-on biologics market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Global Biosimilars and Follow-on Biologics Market forecasts from 2020-2030.
Along with revenue prediction for the overall world market for biosimilars, our investigation shows forecasts to 2029 for 8 individual therapeutic submarkets:
This report also shows revenue to 2030 for 11 individual submarkets within the above segments:
Our analyses show individual revenue forecasts to 2030 for 17 national markets:
Our study discusses the leading companies that are involved in the biosimilars and follow-on biologics industry:
Our study provides a SWOT analysis of the biosimilars and follow-on biologics market.
Our study discusses pressures, opportunities and other events affecting the biosimilars industry and market, including these influences:
Visiongain's study is intended for anyone requiring commercial analyses for the biosimilars and follow-on biologics market. You find data, trends and predictions.
Buy our report today Global Biosimilars and Follow-On Biologics Market 2020-2030: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietin's, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones, Blood Disorders, Growth Hormone Deficiency, Autoimmune Diseases, Cancer, Diabetes, Infectious Diseases.
Visiongain is a trading partner with the US Federal Government
Visiongain is a trading partner with the US Federal Government.